87 studies found for:    "Liposarcoma"
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Conditions: Liposarcoma;   Surgically Unresectable Liposarcoma;   Metastatic Liposarcoma
Intervention: Drug: pazopanib
2 Completed
Has Results
Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma
Condition: Liposarcoma,Myxoid
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
3 Unknown  Brostallicin Clinical Trial for Myxoid Liposarcoma
Condition: Myxoid Liposarcoma
Intervention: Drug: Brostallicin
4 Recruiting Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
Condition: Myxoid Liposarcoma of Soft Tissue
Intervention: Radiation: dose reduction of preoperative radiotherapy in MLS
5 Recruiting Selinexor in Advanced Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Selinexor;   Drug: Placebo
6 Recruiting Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Condition: Liposarcoma
Interventions: Drug: HDM201;   Drug: LEE011
7 Recruiting A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Soft Tissue Sarcoma
Intervention: Drug: ribociclib
8 Active, not recruiting Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma
Condition: Liposarcoma
Intervention: Radiation: Radiotherapy
9 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
10 Suspended Ph II Cabazitaxel/Ifosfamide DD Liposarcoma
Condition: Dedifferentiated Liposarcoma
Interventions: Drug: Cabazitaxel;   Drug: Prolonged infusional ifosfamide
11 Recruiting Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum
Conditions: Retroperitoneal Liposarcoma;   Retroperitoneal Leiomyosarcoma;   Chondrosarcoma
Intervention: Drug: Nilotinib-adriamycin
12 Active, not recruiting A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
13 Completed
Has Results
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Condition: Advanced Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
14 Active, not recruiting Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial
Condition: Advanced and / or Metastatic Liposarcoma
Intervention: Drug: Pazopanib
15 Suspended Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients With Previously Treated, Unresectable Myxoid Liposarcoma
Condition: Liposarcoma
Interventions: Drug: efatutazone;   Drug: placebo
16 Recruiting Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Conditions: Conventional Chondrosarcoma;   Myxoid Liposarcoma;   Mesenchymal Chondrosarcoma;   Dedifferentiated Chondrosarcoma
Intervention: Drug: sirolimus and cyclophosphamide
17 Active, not recruiting PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
Conditions: Sarcoma;   Liposarcoma
Intervention: Drug: Palbociclib
18 Terminated
Has Results
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
Conditions: Adult Liposarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: nelfinavir mesylate;   Procedure: biopsy;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Genetic: gene expression analysis;   Genetic: western blotting;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique
19 Recruiting SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo
20 Recruiting Study of Abemaciclib in Dedifferentiated Liposarcoma
Conditions: Sarcoma;   Dedifferentiated Liposarcoma
Intervention: Drug: Abemaciclib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years